Abstract

Her4 is a transmembrane receptor tyrosine kinase belonging to the ErbB-EGFR family. It plays a vital role in the cardiovascular and nervous systems, and mutations in Her4 have been found in melanoma and lung cancer. The kinase domain of Her4 forms a dimer complex, called the asymmetric dimer, which results in kinase activation. Although a crystal structure of the Her4 asymmetric dimer is known, the dimer affinity and the effect of the subsequent phosphorylation steps on kinase domain conformation are unknown. We report here the use of carboxyl-group footprinting MS on a recombinant expressed, Her4 kinase-domain construct to address these questions. Carboxyl-group footprinting uses a water-soluble carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, in the presence of glycine ethyl ester, to modify accessible carboxyl groups on glutamate and aspartate residues. Comparisons of Her4 kinase-domain monomers versus dimers and of unphosphorylated versus phosphorylated dimers were made to map the dimerization interface and to determine phosphorylation induced-conformational changes. We detected 37 glutamate and aspartate residues that were modified, and we quantified their extents of modification by liquid chromatography MS. Five residues showed changes in carboxyl-group modification. Three of these residues are at the predicted dimer interface, as shown by the crystal structure, and the remaining two residues are on loops that likely have altered conformation in the kinase dimer. Incubating the Her4 kinase dimers with ATP resulted in dramatic increase in Tyr-850 phosphorylation, located on the activation loop, and this resulted in a conformational change in this loop, as evidenced by reduction in carboxyl-group modification. The kinase monomer-dimer equilibrium was measured using a titration format in which the extent of carboxyl-group footprinting was mathematically modeled to give the dimer association constant (1.5-6.8 × 10(12) dm(2)/mol). This suggests that the kinase-domain makes a significant contribution to the overall dimerization affinity of the full-length Her4 protein.

Highlights

  • From the ‡Department of Chemistry, Washington University, St

  • Several important questions remain about this model including, [1] what is the dimerization affinity of the asymmetric kinase dimer, [2] what is the conformation of these kinase dimers on the surface of a lipid membrane, [3] how do these conformations change when different ErbBEGFR family members form heterodimers, and [4] how does the subsequent phosphorylation step affect the conformation of the Her4 kinase domain? In this paper, we combined a reconstituted, in vitro model system with MS-based footprinting to address these questions

  • Carboxyl-Group Footprinting Method—In this MS-based footprinting, protein samples are modified by a coupling reaction between the carboxyl side chain of proteins and the primary amine of glycine ethyl ester (GEE), a reaction driven by EDC (Fig. 1A)

Read more

Summary

Introduction

From the ‡Department of Chemistry, Washington University, St. Louis, MO 63130, §Division of Oncology, Department of Medicine and ¶Department of Cell Biology and Physiology, Washington University School of Medicine, St. As with other receptor tyrosine kinases, ligand binding stimulates Her dimerization, which results in activation of its tyrosine-kinase domain and autophosphorylation of multiple Tyr residues [6,7,8]. A landmark study on EGFR showed that the isolated EGFR kinase domain can form dimers that activate the tyrosine kinase by an allosteric mechanism [9]. This model of ErbB-EGFR kinase activation, which is called the Asymmetric Dimer model, applies in vivo to the entire ErbB family, including Her4 [11, 12, 15, 16].

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call